345 related articles for article (PubMed ID: 34903008)
1. Construction and validation of a novel pyroptosis-related signature to predict prognosis in patients with cutaneous melanoma.
Niu Z; Xu Y; Li Y; Chen Y; Han Y
Math Biosci Eng; 2022 Jan; 19(1):688-706. PubMed ID: 34903008
[TBL] [Abstract][Full Text] [Related]
2. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma.
Li AA; Zhang Y; Tong WL; Chen JW; Huang SH; Liu JM; Liu ZL
Int J Gen Med; 2022; 15():6145-6163. PubMed ID: 35855761
[TBL] [Abstract][Full Text] [Related]
4. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
5. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
6. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
Liang L; Mai S; Mai G; Chen Y; Liu L
Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
[TBL] [Abstract][Full Text] [Related]
7. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
8. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
10. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
11. Identification of Pyroptosis-Relevant Signature in Tumor Immune Microenvironment and Prognosis in Skin Cutaneous Melanoma Using Network Analysis.
Zhu Y; Han D; Duan H; Rao Q; Qian Y; Chen Q; Du X; Ni H; Wang S
Stem Cells Int; 2023; 2023():3827999. PubMed ID: 36818162
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma.
Yu H; Bai X; Zheng W
Dis Markers; 2022; 2022():9124216. PubMed ID: 35535333
[TBL] [Abstract][Full Text] [Related]
13. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
Ye Y; Dai Q; Qi H
Cell Death Discov; 2021 Apr; 7(1):71. PubMed ID: 33828074
[TBL] [Abstract][Full Text] [Related]
14. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
[TBL] [Abstract][Full Text] [Related]
15. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
[TBL] [Abstract][Full Text] [Related]
16. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
17. The Pyroptosis-Related Signature Composed of GSDMC Predicts Prognosis and Contributes to Growth and Metastasis of Hepatocellular Carcinoma.
Li M; Jiang Q; Liu X; Han L; Chen S; Xue R
Front Biosci (Landmark Ed); 2023 Oct; 28(10):235. PubMed ID: 37919059
[TBL] [Abstract][Full Text] [Related]
18. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
19. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
20. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma.
Lin W; Tan ZY; Fang XC
SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
